Follow-up in Rivaroxaban patients in setting of thromboembolism

• Research type

  Research Study

• Full title

  FIRST Registry: Follow-up in Rivaroxaban Patients in the Setting of Thromboembolism

• IRAS ID

  161050

• Contact name

  Roopen Arya

• Contact email

  roopen.arya@nhs.net

• Sponsor organisation

  King's College Hospital NHS Foundation Trust

• Clinicaltrials.gov Identifier

  NCT02248610

• Duration of Study in the UK

  5 years, 0 months, 1 days

• Research summary

  We intend to study the incidence of long term complications (venous thromboembolism (VTE), post thrombotic syndrome and chronic thrmoboembolic pulmonary hypertension) for VTE patients treated with rivaroxaban without bridging heparin (up to 5 years) in routine clinical practice (no additional actions will be required other than routine clinical practice of the treating hospital or GP practice).

• REC name

  West of Scotland REC 4

• REC reference

  14/WS/1120

• Date of REC Opinion

  9 Oct 2014

• REC opinion

  Favourable Opinion